Basic information Safety Supplier Related

ASPERLIN

Basic information Safety Supplier Related

ASPERLIN Basic information

Product Name:
ASPERLIN
Synonyms:
  • U 13933
  • ASPERLIN
  • ASPERLINE
  • Asperlin (usan)
  • D02999
  • D-galacto-Oct-2-enonic acid, 6,7-anhydro-2,3,8-trideoxy-, δ-lactone, 4-acetate
CAS:
30387-51-0
MF:
C10H12O5
MW:
212.2
Product Categories:
  • Antibiotic
Mol File:
30387-51-0.mol
More
Less

ASPERLIN Chemical Properties

Boiling point:
360.4±42.0 °C(Predicted)
Density 
1.28±0.1 g/cm3(Predicted)
More
Less

Safety Information

HS Code 
29419000
More
Less

ASPERLIN Usage And Synthesis

Uses

Antibacterial; antineoplastic.

in vivo

Asperlin (40-80 mg/kg; p.o.; once daily for 12 weeks) effectively prevents the development of obesity, stimulates energy expenditure and modulates gut microbiota in high-fat diet (HFD)-fed mice[2].
Asperlin (80mg / kg; p.o.; once daily for 12 weeks) remarkably suppresses atherosclerotic plaque formation in the aorta, as revealed by the reduced aortic dilatation and decreased atherosclerotic lesion area in high-fat diet (HFD)-fed ApoE-/- mice[5].

Animal Model:C57BL/6J mice (8-weeks old, weighing 20-25g) were fed with a high-fat diet (HFD) to induce obesity[2]
Dosage:40, 80 mg/kg
Administration:Oral gavage (p.o.), once daily for 12 weeks
Result:Showed lower body weight, and food intake was not varied.
Reduced the blood levels of total cholesterol (TC), triglycerides (TG) and low-density lipoprotein (LDL-c). Liver TC, TG contents and fat vacuoles were also substantially reversed.
Increased energy expenditure and enhanced thermogenic gene (PGC1α, UCP1, CIDEA, CPT1B, FATP1, CYTO-C) expression in adipose tissue.
Increased the diversity of the gut microbes. Significantly shifted the structure of the gut microbiota.
Animal Model:Male C57BL/6 J and C57BL/6 J ApoE-/- mice (6-8 weeks, weighting 20-25 g)[5]
Dosage:80 mg/kg
Administration:Oral gavage (p.o.), once daily for 12 weeks
Result:Remarkably suppressed atherosclerotic plaque formation in aorta, reduced the white atherosclerotic lesions, effectively inhibited aortic dilatation in ApoE-/- mice.

ASPERLINSupplier

BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Zhejiang Huida Biotech Co., LTD
Tel
0571-89903882 18679456698
Email
mingxinzhu@huidabiotech.com
TCI (Shanghai) Chemical Trading Co., Ltd.
Tel
021-61109150
Email
sales@tcisct.com
Zhejiang Huida Biotech Co., LTD
Tel
0571-0571-89903882 15990081639
Email
sunshixuan@huidabiotech.com
More
Less

ASPERLIN(30387-51-0)Related Product Information